Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

Community Health Advocates for Motivating PAP Use in Our Neighborhoods.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The purpose of this research is to compare the impact of motivational enhancement therapy (MET), delivered by culturally congruent community health care workers (CHWs) versus usual care patients with previously untreated moderate-to-severe obstructive sleep apnea (OSA) on adherence to positive airway pressure (PAP) therapy.

Who May Be Eligible (Plain English)

Inclusion Criteria - ≥ 18 years of age - Moderate-to-severe OSA - Available to attend study visits and sessions - Reliable access to a phone Exclusion Criteria - Prior or current use of PAP therapy or other treatment (e.g., oral appliance) for OSA - History of upper airway surgery for OSA - Moderate to severe insomnia - Commercial drivers - Use of non-standard PAP including adaptive servo-ventilation or bi-level positive airway pressure - Report of motor vehicle accident or near-miss due to sleepiness within the 2 previous years - Unstable medical conditions that may preclude enrollment in the protocol such as: uncontrolled angina and/or congestive heart failure, uncontrolled blood pressure or resistant hypertension, severe chronic obstructive pulmonary disease, cancer, and active psychiatric disease (e.g., major depression) - Other sleep disorders (e.g., circadian rhythm disorder) - Use of supplemental oxygen during wakefulness or sleep - Central sleep apnea, obesity hypoventilation syndrome or Cheyne-Stokes respiration based on the home sleep apnea test - Resting awake oxygen saturation (SpO2) \< 90% - Participation in another clinical trial Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria * ≥ 18 years of age * Moderate-to-severe OSA * Available to attend study visits and sessions * Reliable access to a phone Exclusion Criteria * Prior or current use of PAP therapy or other treatment (e.g., oral appliance) for OSA * History of upper airway surgery for OSA * Moderate to severe insomnia * Commercial drivers * Use of non-standard PAP including adaptive servo-ventilation or bi-level positive airway pressure * Report of motor vehicle accident or near-miss due to sleepiness within the 2 previous years * Unstable medical conditions that may preclude enrollment in the protocol such as: uncontrolled angina and/or congestive heart failure, uncontrolled blood pressure or resistant hypertension, severe chronic obstructive pulmonary disease, cancer, and active psychiatric disease (e.g., major depression) * Other sleep disorders (e.g., circadian rhythm disorder) * Use of supplemental oxygen during wakefulness or sleep * Central sleep apnea, obesity hypoventilation syndrome or Cheyne-Stokes respiration based on the home sleep apnea test * Resting awake oxygen saturation (SpO2) \< 90% * Participation in another clinical trial

Treatments Being Tested

BEHAVIORAL

Motivational Enhancement Therapy

Motivational Enhancement Therapy (MET) is based on the principles of motivational interviewing and is designed to promote self-efficacy and maximize behavioral change. MET will be given via phone and/or in person (approximately 30 minutes) at baseline, week 1, week 2, week 4, and week 8.

DEVICE

Positive Airway Pressure (PAP) therapy

Positive Airway Pressure (PAP) therapy will be administered as per standard of care.

Locations (1)

University of Miami
Miami, Florida, United States